Jun 15, 2020 / 01:00AM GMT
Presentation
Jun 15, 2020 / 01:00AM GMT
=====================
Corporate Participants
=====================
* Janet Payne
Healius Limited - Group Executive of Corporate Affairs
* Malcolm W. Parmenter
Healius Limited - MD, CEO & Director
* Maxine Jacquet
Healius Limited - CFO
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Marquee - Healthcare analyst
* Chris Cooper
Goldman Sachs Group, Inc., Research Division - Research Analyst
* David A. Low
JPMorgan Chase & Co, Research Division - Research Analyst
* David Bailey
Macquarie Research - Research Analyst
* Han van der Boon
Robeco Institutional Asset Management US, Inc. - Portfolio Manager
* John Deakin-Bell
Citigroup Inc., Research Division - Director and Head of Healthcare in Australia & New Zealand
* Lyanne Harrison
BofA Merrill Lynch, Research Division - VP
* Nicolette Quinn
Morningstar Inc., Research
Healius Ltd
(ASX:HLS)
A$
0.36
+0.0050 (+1.39%)
Market Cap: 265.05 Mil
Enterprise Value: 1.15 Bil
PE Ratio: 0
PB Ratio: 0.46
GF Score: 53/100 Healius Ltd Sales of Medical Centres and Market Update Presentation Transcript
Jun 15, 2020 / 01:00AM GMT
Release Date Price:
A$2.79
(+18.97%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot